Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
If Congress takes no action, Medicare payments to physicians will be slashed by 27.4% on January 1. If this sounds familiar, it is. Roughly annually,
Today in TIE: Reflex, Austin takes another look at Romney’s reform ideas, and reviews the inconsistent way we worry about exchanges depending upon the age
This morning, the federal district court in DC issued a preliminary injunction blocking the new FDA cigarette warnings until the full lawsuit can be heard.
Thaddeus Pope provides the story of a family that has sued a health care system for failing to honor a “do not intubate” order stated
I edit the Journal of Health, Politics, Policy, and Law’s new section: Point-Counterpoint. In this issue, public health experts discuss what to do about intentional non-vaccination.
Let’s think this through. I’ll start. You chime in in the comments. Medicare: Private plans participate in Medicare under Medicare Advantage and, for drugs, through
In the WSJ, Scott Gottlieb identifies the cause of the shortages of injectable cancer drugs as a combination of safety issues and Medicare “price controls”
When Congress talks about “fraud and abuse” in health care, they inappropriately lump together two quite different categories. One are criminals who bill for services
Lyle Fettig has an interesting post on what adjective is best used to describe the patient needing palliative care: Serious v. Chronic v. Life-limiting v.
Reihan Salam* was surprised by my reaction to Mitt Romney’s Medicare plan. He thinks he sees the signs of competitive bidding in it. I think
Before anyone, including me, gets too starry eyed about competitive bidding among Medicare plans, it’s worth repeating its limitations. Igor Volsky expressed some recently, including
Despite my deep and wide study of competitive bidding among Medicare plans,* I had not, until moments ago, read Yuval Levin’s late September piece on it,